Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability and Platelet Aggregation
1 other identifier
observational
9
1 country
1
Brief Summary
Our objective is to determine whether or not the presence of hemoperitoneum in trauma patients is associated with increased Carbon Monoxide (CO) formation, and to determine if elevated Carbon Monoxide levels are associated with cardiovascular depression, impaired platelet aggregation, and/or multiple organ failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 4, 2012
CompletedFirst Posted
Study publicly available on registry
May 8, 2012
CompletedMay 14, 2012
May 1, 2012
1.5 years
May 4, 2012
May 11, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
•Establish a method for reliably measuring CO excretion in patients.
96 hours
Study Arms (1)
no treatment
Interventions
Eligibility Criteria
patients in the ICU on a ventilator
You may qualify if:
- Hospitalized males 18 years of age or older,
- Diagnosis of isolated blunt OR blunt and penetrating trauma,
- Admitted or expecting to be admitted to the Intensive Care Unit,
- On mechanical ventilation, and
- Written informed consent obtained
You may not qualify if:
- Female gender, (Females will be excluded from this study as the menstrual cycle and other estrogen variations are known to be associated with cyclic changes in CO production adding a potential confounder to the interpretations of our findings.)
- Diagnosis of isolated penetrating trauma,
- Acute hemothorax or pneumothorax,
- Treatment with antiaggregants (ASA, clopidogrel, aggrenox or ticlopidine),
- Enrollment in another research study,
- Prisoners,
- Inability to perform CO measurement within 96 hours after hospital admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
San Antonio, Texas, 78229, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Johnson, PhD
University of Texas
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2012
First Posted
May 8, 2012
Study Start
November 1, 2009
Primary Completion
May 1, 2011
Study Completion
May 1, 2011
Last Updated
May 14, 2012
Record last verified: 2012-05